respiratory Flashcards

1
Q

what is asthma?

  • chronic inflammatory disease of the _____ and _____ tissue
  • airway changes:
  • -the muscles surrounding the bronchial tubes _____, airways _____
  • -the lining of the airway becomes _____ and _____
  • -there is an increase in _____ production
A
bronchial tubes
lung
constrict 
narrow
inflamed 
swollen
mucus
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

asthma triggers

  • respiratory infections-viral, _____
  • allergens-pollens, _____, animal dander
  • _____ (_____)
  • work stimuli-flour, farmers hay mold
  • environment–_____ air, _____ smoke
  • emotions- _____, _____
  • _____- especially in _____ climate
  • drugs/preservatives- _____, _____, _____
A
pneumonia 
dust mites
gastroesophageal reflux (GERD)
cold
tobacco
anxiety
stress
exercise 
cold dry
ASA
sulfites
beta blockers
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

signs and symptoms

  • use of _____ muscles (_____, _____ and _____ of the neck)
  • _____ pulse (weak during _____ and strong during _____)
  • over inflation of the _____
  • _____ color of skin and nails may indicate _____
  • responds to standard treatment with _____ and _____
  • _____: mortality rate 70%
A
accessory
sternocleidomastoid 
external intercostals 
scalene muscles 
paradoxical
inspiration
expiration 
chest
blue
cyanosis
bronchodilators 
steroids
status asthmaticus
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

asthma

  • clinically: recurrent episodic bouts of _____
  • two phases:
  • –acute-phase (_____) response
  • –within a _____ to _____ challenge
  • –_____, _____, _____ tightness, _____
  • –lasts a few hours
  • -late phase response (_____)
  • –chronic _____, _____
  • –occurs in 2 ot 6 hours and lasts up to _____ to _____ hours
A
bronchospasm
immediate
few mins
antigen
bronchospasm 
shortness of breath
chest
wheezing 
inflammation
wheeze 
hyper-responsiveness 
12
24
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

immediate (acute) phase

  • bronchial smooth muscle constriction
  • -mediator release from _____ cells and other immunologic responses
  • –_____; _____ factors
  • –_____ (LTB4; LTC4; LTD4; LTE4)
  • —LTB4- is a _____
  • –_____, neutral _____, _____ (D2)
  • –reversible with treatment
  • –short term relief with _____
  • –_____ may help in allaying symptoms
A
sensitized mast
histamine
eosinophil chemotactic 
leukotrienes 
chemo-attractant 
tryptase 
proteases
prostaglandins 
bronchodilators 
oral steroids
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

late phase response

  • peak within 4-8 hours and may last for 12-24 hours
  • _____ characterized by cellular _____
  • -_____, _____, GM-CSF (_____ CSF)
  • –releases of _____ (IL4, IL5, IL9, I30, TNF, TGF) which activate _____ and _____
  • -activated _____ and _____
A
chronic inflammation 
infiltration 
mast cells
lymphocytes 
granulocyte macrophage 
cytokines
eosinophils 
neutrophils 
eosinophils 
neutrophils
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

goals of asthma therapy

  • prevent troublesome symptoms- _____, _____ in night, am, after _____
  • maintain normal _____ function
  • maintain normal activity
  • prevent recurrent _____/_____
  • optimal drug therapy with no side effects
A
cough
breathlessness 
exercise 
exacerbations
hosp
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

pharmacologic agents for asthma

  • quick-relief (rescue) medications
  • -agents that directly relaxes _____; prompt reversal of acute airflow obstruction
  • -_____ (short acting _____)
  • -_____ (Ventolin); _____
  • anticholinergics
  • -_____ (atrovent); _____ (Spiriva)
  • corticosteroids:
  • -_____, _____, _____
A
bronchial smooth muscles
SABA
beta agonist
albuterol 
terbutaline 
ipratropium 
tiotropium
fluticasone
prednisone 
triamcinolone
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q
pharmacologic agents for asthma 
long-term control (controller) medications:
-corticosteroids, inhaled: 
--\_\_\_\_\_, \_\_\_\_\_, \_\_\_\_\_
-LABA (long acting beta2 agonist)
--\_\_\_\_\_ (serevent); \_\_\_\_\_; \_\_\_\_\_/\_\_\_\_\_ (Advair)
-leukotriene receptor antagonist (LTRA)
--\_\_\_\_\_ (Singulair); \_\_\_\_\_ (Accolate)
-5-lipoxygenase inhibitors 
--\_\_\_\_\_ (Zyflo)
-mast cell stabilizer (also inhibits \_\_\_\_\_; recruitment)
--\_\_\_\_\_ (Gastrocrom); \_\_\_\_\_ (Alocril)
-methylxanthines
--\_\_\_\_\_
-immunomodulators
-\_\_\_\_\_ (Xolair)
A
beclomethasone 
budesonide
fluticasone 
salmeterol 
formoterol 
salmeteral/flunisolide
montelukast 
zirfarlulast 
zileuton
eosinophi
cromolyn 
nedocromil 
theophylline 
omalizumab
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

types of asthma

  • _____: patients with episodic illness with extended symptom-free periods
  • _____ or _____: daily symptoms or symptoms several times/week without extended symptom free periods
  • _____: daily symptoms during an allergy season (also referred to as “seasonal”) asthma
A

intermittent
persistent
chronic
allergic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q
status asthmaticus 
acute severe asthma
-life threatening emergency 
-requires rapid, aggressive treatment 
-immediate treatment:
--activate office emergency protocol 
--\_\_\_\_\_ by mask
---\_\_\_\_\_ to help liquefy mucus
--\_\_\_\_\_
--patients will require \_\_\_\_\_
A

oxygen
humidified air
albuterol
hospitalization

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

symptoms of poorly controlled persistent asthma

  • waking up at night > _____/month
  • refilling _____ (_____) >1/month
  • exercise-induced _____
  • missing _____
  • missing _____
  • _____
A
2
albuterol 
ventolin
bronchoconstriction
school
work
hospitalization
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

quick relief medication RELIEVER/RESCUE

  • non-selective beta-2 agonist: _____, _____
  • short-acting beta2-agonists: _____, _____
  • _____
  • systemic _____
A
epinephrine 
isoproterenol 
terbutaline 
albuterol
anticholinergics 
corticosteroids
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

beta 2-agonists (albuterol)

  • relax airway _____ or relieve _____
  • used for treatment of _____ episodes of _____ and prevention of _____-induced asthma
  • for _____ asthmatic attack
  • _____
  • _____ (Ma Huang)
  • _____
A
smooth muscle
bronchospasm 
intermittent 
bronchospasm 
exercise 
acute 
epinephrine 
ephedrine 
isoproterenol
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q
beta 2 agonists 
beta-adrenoceptor agonists 
-mechanism of action 
--stimulate B2 receptor \_\_\_\_\_ 
---activate \_\_\_\_\_
---increase \_\_\_\_\_
---\_\_\_\_\_ activation
---inactivation of \_\_\_\_\_ 
-result in \_\_\_\_\_ response by relaxation of bronchial smooth muscle
A
G protein coupled receptor system
adenylyl cyclase 
cAMP
protein kinase A
myosin light chain kinase
bronchodilator
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q
adverse effects
beta-adrenoceptor agonists adverse effects 
-skeletal muscle \_\_\_\_\_ 
-\_\_\_\_\_ at high doses 
-\_\_\_\_\_ with excessive use
-loss of \_\_\_\_\_
-\_\_\_\_\_
-\_\_\_\_\_: excessive use of short-acting sympathomimetics
A
tremors
tachycardia 
arrhythmias 
responsiveness 
tolerance 
tachyphylaxis
17
Q
beta 2 agonists 
short acting 
-\_\_\_\_\_ (Proventil, Ventolin)
-\_\_\_\_\_ (bricanyl, brethine)
-\_\_\_\_\_ (alupent, metaprel)

pharmacokinetics:

  • rapid onset of action 15-30 mins
  • peak effect in 30-60 mins
  • duration of action: 4-6 hours
A

albuterol
terbutaline
metaproterenol

18
Q

anticholinergics

  • _____ (atrovent), _____ (Spiriva)
  • blockade of these cholinergic receptors decreases the formation of _____ (_____), resulting in decreased contractility of smooth muscle
  • _____
A

ipratropium
tiotropium
cyclic guanosine monophosphate (cGMP)
bronchodilation

19
Q

anticholinergic drugs
muscarinic antagonists
-effects (_____)
–effective in 33% of patients
–not well absorbed into circulation - _____ compounds
–more effective and less toxic than _____ in COPD patients

  • pharmacokinetics (_____)
  • -_____ delivery, minimally absorbed systemically
  • -_____ metabolized, little system action
  • -excessive doses - _____ like effects
  • -does not cause _____ or _____
A
inhalation
quarternary ammonium 
beta agonists 
localized 
rapidly 
atropine 
tremor 
arrhythmias
20
Q

systemic corticosteroids

  • used for _____ exacerbations
  • _____, _____, _____
  • decrease _____ and improve _____ production
  • oral or _____
A
moderate-to-severe 
hydrocortisone
prednisone
dexamethasone 
inflammation
mucus
IV
21
Q

corticosteroids
mechanism of action
-bind to intracellular receptors and activate _____ (GRE) in the cell nucleus
–reduce the activity of _____ and inhibit _____ expression (prostaglandin production) and LOX (lipooxgenase) production

  • mechanism of action
  • -inhibits _____
  • -inhibit expression of _____
  • -inhibit expression of _____
  • -_____ stabilization
A
glucocorticoid response element
phospholipase A 2
COX-2
phospholipase A2
COX-2
LOX
membrane
22
Q

controller medications

  • inhaled _____
  • long acting _____
  • _____ modifiers
  • slow-release _____
A

corticosteroids
B2 agonists
leukotriene
theophylline

23
Q
inhaled corticosteroids 
agents 
-\_\_\_\_\_ (Rhinocort)
-\_\_\_\_\_ (belcovent)
-\_\_\_\_\_ (Flonase, Flovent)
-\_\_\_\_\_ (Nasacort)
-\_\_\_\_\_ (omnaris): most recently approved inhaled steroid is an ester prodrug which converts into \_\_\_\_\_ in the lower bronchial epithelium 
  • adverse effects
  • -deposition of drugs in mouth and upper airway lead to _____ (_____)
A
budesonide 
beclomethasone 
fluticasone 
triamcinolone 
ciclesonide 
des-isobutyrylciclesonide
oral candidiasis (thrush)
24
Q

adverse effects (inhalation)

  • occasionally, small degree of _____ (rarely significant)
  • _____
  • -rinse mouth
  • children, mild growth retardation

adverse effects (oral)

  • _____, _____, _____
  • -_____ suppression, can be reduced by alternate-day therapy
A
adrenal suppression
oropharyngeal candidiasis 
osteoporosis 
cataract
hypertension 
adrenal
25
Q

long-acting inhaled beta 2 agonists

  • _____ (oxeze) and _____ (serevent)
  • adjunct therapy to _____
  • available alone and as combination therapy with _____
  • especially helpful for a night time symptoms and _____ induced asthma
  • not to be used to treat acute symptoms or _____
A
formoterol
salmeterol 
inhaled steroids 
steroids
exercise 
exacerbations
26
Q

leukotriene antagonists

  • _____ (5-lipo-oxygenase inhibitor)
  • _____
  • block _____ receptors that mediate airway _____, edema, _____ and secretion of thick, viscous mucus
  • administered _____
  • clinical application
  • -_____, _____ and treatment
  • -NOT useful during _____ attack or _____
A
zileuton
zyflo
leukotriene 
inflammation 
btonchoconstriction 
orally 
acute
status asthmaticus
27
Q

leukotrienes modifiers

  • _____ (Montelukast), _____ (Zafirlukast)
  • they prevent binding of _____ to target tissues preventing _____, mucosal edema, bronchial hyper-reactivity
  • beneficial in patients with exercise - induced bronchospasm (already on _____) and patients with _____
A
Singulair 
accolate
leukotrienes 
bronchoconstriction 
environmental allergies
28
Q

leukotrienes modifiers

  • _____ (Singulair) and _____ (accolate)
  • selective and competitive leukotriene receptor antagonist
  • -_____: LTC4, LTD4, LTE4
  • -_____: LTC4, LTD4, LTE4
  • clinical application
  • -_____, prophylaxis and treatment
  • -NOT useful during _____ attack or _____
A
montelukast 
zafirluast
montelukast 
zafirluast 
asthma
acute 
status asthmaticus
29
Q

theophylline

  • class of _____
  • _____, _____ and _____
  • mild to moderate _____
  • may have mild _____ effects and _____ effects
  • enhances _____ secretion
  • serum levels measurable
A
methyl-xanthines
theophylline 
theobromine
caffeine 
bronchodilator 
anti-inflammatory
immunosuppressant 
catecholamine
30
Q

theophylline

  • variable t1/2 life- reduced in _____ and _____ age 1 to 9
  • metabolism by _____- watch drug interactions
  • -_____: severely decreases clearance of theophylline

adverse effects:

  • GI (_____), CNS (_____) and cardiac stimulation (_____)
  • CNS effects- restlessness, _____, dizziness, _____
  • death!!
A
smokers
children
CYP450
ciprofloxacin
diarrhea
convulsions 
arrhythmias 
insomnia 
seizures
31
Q

mast cell stabilizers

  • _____ (intal)
  • stabilize mast cell _____
  • not effective during an _____ asthma attack
  • prevents mast cells from rupturing and spilling _____ (degranulation) after initial contact with _____
  • administered via _____ or _____ spray
  • -prevent release of _____
  • -has no intrinsic _____ activity
  • -has no _____ activity
A
cromolyn sodium
membrane 
acute
histamine 
antigen
inhalation
intranasal 
inflammatory mediators
bronchodilator 
antihistamine
32
Q

mast cell stabilizer
-_____ (disodium cromoglycate) and _____

clinical uses:

  • _____ (inhalation)
  • -especially in children
  • _____ (oral)
  • _____ (hay fever)
  • -_____ irritation
  • -_____ irritation
A
cromolyn
nedocromil
asthma
food allergy
topical 
conjunctival
nasopharyngeal tract
33
Q

anti-IgE antibodies

  • omalizumab (Xolair)
  • -_____ developed through molecular biology research (mice)
  • -binds to _____ on the surface of _____ and _____ but foes not activate already bound IgE, thus does not _____ cells
  • -indicated for moderate to severe cases which are inadequately controlled by _____
  • -used in asthma reactive to a specific _____
A
monoclonal antibody
IgE
mast cells
basophils 
degranulate
inhaled corticosteroids 
allergen
34
Q

anti-IgE antibodies

  • omalizumab (Xolair)
  • -administered via _____ injection every 3 or 4 weeks
  • -lowers _____ to undetectable levels, m reducing early as well as late _____ response
  • -adverse effects:
  • –injection site reaction (_____)
  • –_____; _____; myopathy
  • –_____ reaction
A
subcutaneous 
IgE
bronchial 
thrombophlebitis 
pharyngitis 
earache 
anaphylactic
35
Q

beta blockers

  • inducers of _____
  • used for Rx _____/_____
  • blocking beta 2 receptors in airways with nonselective beta blockers (propranolol)
  • selective beta blockers (cardio-selective blockers) preferred: _____
  • less _____ than nonselective beta blockers
A

bronchoconstriction
hypertension
arrhythmias
atenolol

36
Q

drug-induced bronchospasm

  • ASA and NSAIDs
  • -can induce severe _____
  • sulfites: _____
  • ACE inhibitors
  • -can cause cough (_____)
  • -cough is due to release of _____
  • in asthmatics… since cough is a symptom of asthma and a side effect of _____ use these drugs carefully
A
bronchospasm 
preservatives
lisinopril
prostaglandins 
ACE inhibitors